Methods of therapeutic treatment using amounts of retinoid components

Details for Australian Patent Application No. 2004261286 (hide)

Owner Allergan, Inc.

Inventors Sefton, John; Gibson, John R.

Agent Davies Collison Cave

Pub. Number AU-A-2004261286

PCT Pub. Number WO2005/011667

Priority 60/491,143 30.07.03 US

Filing date 29 July 2004

Wipo publication date 10 February 2005

International Classifications

A61K 31/203 (2006.01)

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011667 Priority application(s): WO2005/011667

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261290-Apparatus and methods for applying neural stimulation to a patient

2004261283-Bicyclic compounds and compositions as PDF inhibitors